MTOR-dependent modulation of gastric nesfatin-1/NUCB2

Cellular Physiology and Biochemistry

Volumn 29, Issue 3-4, 2012, Pages 493-500

  Li, Ziru ^a   Xu, Geyang ^a   Li, Yin ^a   Zhao, Jing ^a   Mulholland, Michael W ^b   Zhang, Weizhen ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Gastric hormones; Gastric mTOR; Gastric X A like cells; Nesfatin 1 NUCB2

Indexed keywords

FAT; GASTROINTESTINAL HORMONE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NESFATIN 2; NUCLEOBINDIN 2; RAPAMYCIN; S6 KINASE; S6 KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD INTAKE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH; STOMACH MUCOSA; WESTERN BLOTTING;

MAMMALIA; MUS;

EID: 84859884436     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000338503     Document Type: Article

References (17)

1. Oh IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006;443:709-712. (Pubitemid 44564715)
2. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Tache Y, Sachs G, Lambrecht NW: Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009;150:232-238.
3. Zhang AQ, Li XL, Jiang CY, Lin L, Shi RH, Chen JD, Oomura Y: Expression of nesfatin-1/NUCB2 in rodent digestive system. World J Gastroenterol 2010;16:1735-1741.
4. Pan W, Hsuchou H, Kastin AJ: Nesfatin- 1 crosses the blood-brain barrier without saturation. Peptides 2007;28:2223-2228. (Pubitemid 47600423)
5. Price TO, Samson WK, Niehoff ML, Banks WA: Permeability of the bloodbrain barrier to a novel satiety molecule nesfatin-1. Peptides 2007;28:2372-2381. (Pubitemid 350123562)
6. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Monnikes H, Lambrecht NW, Tache Y: Central nesfatin-1 reduces darkphase food intake and gastric emptying in rats: differential role of corticotropinreleasing factor2 receptor. Endocrinology 2009;150:4911-4919.
7. Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh IS, Ariyama Y, Takahashi H, Okada S, Hashimoto K, Satoh T, Kojima M, Mori M: Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 2010;73:484-490.
8. Ogiso K, Asakawa A, Amitani H, Nakahara T, Ushikai M, Haruta I, Koyama K, Amitani M, Harada T, Yasuhara D, Inui A: Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 2011;32:150-153.
9. Xu G, Li Y, An W, Li S, Guan Y, Wang N, Tang C, Wang X, Zhu Y, Li X, Mulholland MW, Zhang W: Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. Endocrinology 2009;150:3637-3644.
10. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, Witters LA, Ellisen LW, Kaelin WG Jr: Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004;18:2893-2904. (Pubitemid 39602308)
11. Shimizu H, Oh IS, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M: Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009;150:662-671.
12. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, Tanaka S, Dezaki K, Oh IS, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T: Nesfatin- 1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 2009;10:355-365.
13. Yosten GL, Samson WK: The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 2010;298:R1642-1647.
14. Price CJ, Samson WK, Ferguson AV: Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res 2008;1230:99-106.
15. Stengel A, Taché Y: Nesfatin-1-an emerging new player in the brain-gut, endocrine, and metabolic axis. Endocrinology 2011;152:4033-4038.
16. Iwasaki Y, Nakabayashi H, Kakei M, Shimizu H, Mori M, Yada T: Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem Biophys Res Commun 2009;390:958-962.
17. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G: Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004;431:200-205. (Pubitemid 39243474)